Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Why Inuvo INUV deserves a spot on your radar now Modest Uptick 20260507 Xenia XHR Stock Should You Hold Grinds Higher 20260418 TRNS Transcat Inc shares rise nearly five percent even as first quarter 2026 EPS misses consensus analyst expectations OTLK Outlook Therapeutics shares jump almost 20 percent even as Q1 2026 earnings per share miss analyst expectations Jiuzi Holdings JZXN Stock Price Pattern Formation Technical Weakness 20260420 Is Amer Movil AMX stock prone to sharp moves Bearish Sentiment 20260420 VOYA Voya Financial rises 13 percent after Q4 2025 results despite EPS miss and modest year over year revenue growth EU Carmakers Retreat as Chinese Rivals Gain Ground in Shifting European Market Dr RDY Rallies 126 as Bulls Target 1434 20260515 Jim Cramer Backs GE Aerospace Citing Leadership of Larry Culp Is Cadiz CDZIP Still a Buy After 159 Rally 20260515 Westwood WHG Stock Analysis RangeBound Near 1615 20260514 Prothena PRTA Delivers Q1 2026 Beat EPS 061 vs 036 Expected SP Global SPGI Dividend Appeal Highlighted as Mobility SpinOff Approaches Cornwalls Nansledan Development A Retail Blueprint or a Threat to Newquays High Street Americas Simultaneity Nightmare A Traumatic Break from Globalised Norms Manchesters Defining Spirit How Andy Burnhams Economic Philosophy Could Shape UK Policy Dillards Declares 030 Quarterly Dividend as Retailer Continues Shareholder Returns Canadian Big Banks Poised for Solid Q2 Results but Cautious Outlook Amid Soft Economic Backdrop ACIW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued XPOF Q1 2026 Earnings EPS Falls Short as Company Navigates Challenging Environment Nabors Industries Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 MC Q1 2026 Earnings EPS Misses Estimates Amid Uncertain Deal Environment FMX Stock Holds Steady Near 121 as Support and Resistance Levels Define Trading Range Wintergreen Acquisition Corp Rights WTGUR Holds Steady at 010 Amid Minimal Trading Activity Civista Bancshares CIVB Gains 14 as Regional Bank Stock Approaches Key Resistance Level Soren Acquisition Corp Warrants SORNW Edge Higher as Support Levels Hold Global Business Travel Group GBTG Holds Steady Near Key Support Levels